Literature DB >> 8328888

Epidemiology and risk factors for urinary tract infection following spinal cord injury.

K B Waites1, K C Canupp, M J DeVivo.   

Abstract

A prospective study was performed to quantitate frequency and evaluate risk factors for urinary tract infection (UTI) in 64 catheter-free spinal cord injury (SCI) patients who were visited monthly in their homes for up to 1 year by a public health nurse who performed a physical examination and collected urine for culture and urinalysis. Patients also mailed in urine dip slides weekly. UTI was defined as > or = 100,000 CFU/mL. Of 406 UTIs evaluated, 111 (27%) were asymptomatic, whereas 295 (73%) evidenced some sign or symptom possibly referable to the urinary tract. Fever and chills occurred in 43 (11%) episodes. Incidence of UTI overall was 18.4 episodes per person-year at risk whereas the rate for those associated with fever and chills was 1.82 episodes per person-year at risk. Prevalence of UTI was 57.4%. Pyuria was significantly associated with the occurrence of fever and chills (p < 0.0001), with gram-negative bacterial species being relatively more pyogenic than gram-positive species. Demographic and behavioral factors shown to correlate with risk for UTI by rate ratios and 95% confidence intervals were: black ethnicity, poor personal hygiene, and less-than-daily condom catheter changes. Racial difference was observed independently of the other two variables. Bladder drainage method, age, years since injury, income, education, sex, neurologic level, and administration of prophylactic antibiotics were not correlated with increased risk of UTI. This study provides new data regarding characteristics and frequency of UTI following SCI as well as risk factors that influence its development.

Entities:  

Mesh:

Year:  1993        PMID: 8328888     DOI: 10.1016/0003-9993(93)90026-7

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  18 in total

Review 1.  A systematic review of the management of autonomic dysreflexia after spinal cord injury.

Authors:  Andrei Krassioukov; Darren E Warburton; Robert Teasell; Janice J Eng
Journal:  Arch Phys Med Rehabil       Date:  2009-04       Impact factor: 3.966

2.  Proteus bacteriuria is associated with significant morbidity in spinal cord injury.

Authors:  E W Hung; R O Darouiche; B W Trautner
Journal:  Spinal Cord       Date:  2006-12-19       Impact factor: 2.772

Review 3.  Intermittent Catheters: To reuse or not.

Authors:  John P Lavelle
Journal:  Spinal Cord Ser Cases       Date:  2020-09-30

Review 4.  Urinary tract infections in patients with spinal cord lesions: treatment and prevention.

Authors:  F Biering-Sørensen; P Bagi; N Høiby
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria.

Authors:  L E Nicolle; G G Zhanel; G K M Harding
Journal:  World J Urol       Date:  2005-12-31       Impact factor: 4.226

6.  Nosocomial transmission of highly resistant microorganisms on a spinal cord rehabilitation ward.

Authors:  Erik Slim; Christof A Smit; Arthur J Bos; Paul G Peerbooms
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

7.  Intermittent catheterization and recurrent urinary tract infection in spinal cord injury.

Authors:  Leonard U Edokpolo; Karen B Stavris; Harris E Foster
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

8.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 9.  Methenamine hippurate for preventing urinary tract infections.

Authors:  Bon San B Lee; Tushar Bhuta; Judy M Simpson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 10.  Probiotics for preventing urinary tract infection in people with neuropathic bladder.

Authors:  Swee-Ling Toh; Claire L Boswell-Ruys; Bon San B Lee; Judy M Simpson; Kate R Clezy
Journal:  Cochrane Database Syst Rev       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.